Operator Good day, and welcome to the Bionano third quarter 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes ...
Non-GAAP Adjusted EBITDA Loss: $1.5 million. Total ARR (TARR): $9.3 million, up from $8.4 million in Q3 2023. Cash and Cash Equivalents: $18.8 million as of September 30, 2024. Net Cash Used for ...